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Abstract
Introduction: Utilizing single-cell cloning of the COMMA-D cell line engineered to express b-galactosidase (CDb)
cell line, which exhibits normal in vivo morphogenesis, distinct multipotent, ductal-limited, alveolar-limited and
luminal-restricted progenitors, have been isolated and characterized.
Methods: A single-cell suspension of CDb cells was stained using Hoechst dye 33342, followed by analysis and
sorting. Cells that effluxed the dye appeared on the left side of a FACS analysis panel and were referred to as side
population (SP) cells. Cells that retained the dye appeared on the right side and were referred to as non-SP (NSP)
cells. Cells from both SP and NSP regions were sorted and analyzed for outgrowth potential. Additionally,
individual clones were derived from single cells sorted from each region.
Results: There was no difference in the outgrowth potential of the SP vs. NSP cells when 5,000 cells per fat pad
were transplanted. However, individual clones derived from single cells sorted from either SP or NSP regions had
varying growth potential. A total of nine clones were identified, four of which possessed in vivo mammary
outgrowth potential and five of which lacked in vivo outgrowth potential. Two of the clones formed mammary
lobuloalveolar structures that contained both ducts and alveoli and were termed multipotent. Two of the clones
generated either ductal-only or alveolar-only structures and were referred to as ductal-limited or alveolar-limited
progenitor clones, respectively. The ability to expand the clones in vitro allowed for the characterization of their
unique molecular phenotypes. Among the mammary-specific markers tested, high cytokeratin 5 (CK5) expression
was the only marker that correlated with the clones’ outgrowth potential. Among the clones that did not show
any in vivo outgrowth potential when transplanted alone, one clone showed in vivo growth and incorporated into
the mammary lumen when mixed with normal mammary epithelial cells. This clone also showed the highest in
vitro expression of CK8 and Elf5and may represent a luminal-restricted progenitor clone. In addition, six “biclones,”
each made from an SP cell plus an NSP cell, were analyzed. Of these six, three exhibited lobuloalveolar growth.
Conclusions: Distinct immortalized mammary progenitors have been isolated and characterized. Importantly, the
results of this study provide further evidence for the existence of distinct ductal and alveolar mammary
progenitors.
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A mammary gland epithelial hierarchy is beginning to
be defined. In 1996, Smith and colleagues [1] were the
first to demonstrate, on the basis of limiting dilution
transplantation studies, that the mouse mammary gland
contained three distinct progenitors: lobular, ductal and
lobuloalveolar. Later, Wagner and colleagues [2] discov-
ered a parity-identified mammary epithelial subpopula-
tion that was defined as a lobular-restricted progenitor
cell. This cell type was also found in the luminal cell
compartment of ducts, but was not a ductal progenitor
cell. Although previous studies demonstrated the pre-
sence of these progenitors, their phenotypic characteris-
tics were not known until now. Recently, flow cytometry
(FACS) cell sorting followed by transplantation has
allowed the phenotypic and functional characterization
of progenitor and differentiated cells in mouse mam-
mary glands and human breast cells. In the mouse
mammary gland, cell surface markers have been used to
define stem cells as lineage-negative (Lin
-)C D 2 4
+/CD29
high [3] and Lin
-CD24
+/CD49f
high [4], luminal
progenitors as Lin
-CD29
lowCD24
+CD61
+ [5], differen-
tiated estrogen receptor-positive (ER
+) luminal cells as
CD24
+/CD133
+ [6] and myoepithelial progenitors as
CD29
low/CD24
low [6]. In human breast cells, epithelial
cell adhesion molecule-low (EPCAM
low/-)/CD49f
high and
EPCAM
+/CD49f
+/CD10
+/Thy-1
+ represent bipotent
progenitors that generate both luminal and myoepithe-
lial cells [7,8], and EPCAM
+/CD49f
+/AC133
+/MUC-1
+
represent luminal progenitor cells [9]. The differentiated
luminal cells in human breast cells are characterized by
EPCAM
+CD49f
-CD133
+/MUC-1
+ expression, while the
differentiated myoepithelial cells are characterized by
EPCAM
+/CD49f
-/CD10
+/Thy-1
+ expression [9]. How-
ever, the distinct progenitors have not been prospec-
tively isolated, expanded in vivo or in vitro or fully
characterized. Using single-cell cloning, distinct mam-
mary progenitor populations were isolated. The CD cell
line was originally derived from midpregnant BALB/c
mouse mammary glands [10]. This cell line is unique in
that transplantation of cells into the epithelium-free fat
pads of syngeneic female mice generates mammary duc-
tal and alveolar structures. The CD cell line harbors two
distinct p53 mutations: (1) a G-to-C transversion result-
ing in substitution of tryptophan for cysteine at codon
138 and (2) a deletion of the first 21 nucleotides of exon
5 resulting in deletion of codons 123 to 129 [11]. The
experiments in this study were performed using
COMMA-D cell line engineered to express b-galactosi-
dase (CDb) cells. CDb cells were derived from the par-
ental CD cells by transduction with Zeg
+ retrovirus
containing a bifunctional LacZ/Neomycin (b-geo) gener-
ated in Dr Soriano’s laboratory [12,13]. Detailed
sequence analysis of the p53 gene in eight different clo-
nal derivatives of the CDb cell line showed that both
mutant alleles were present in each clone, demonstrat-
ing that the CD cell line is indeed clonal with respect to
the p53 gene and that each cell expresses two distinctive
mutant alleles of p53 [11]. As a result of these p53
mutations, the mammary outgrowths progress to mam-
mary tumors after many months in vivo.H e r ew es h o w
that single-cell cloning of CDb cells resulted in isolated
ductal-limited, alveolar-limited and lobuloalveolar mam-
mary progenitors. Molecular characterization of these
clones using FACS- and immunofluorescence (IF)-
defined markers specific for mammary progenitor activ-
ity. In summary, the progenitor clones derived from the
CDb cell line provide valuable tools for molecular char-
acterization of multipotent and unipotent or committed
mammary progenitors. Furthermore, the malignant
potential of the CDb clones will allow the study of the
role of distinct progenitors in generating heterogeneous
mammary tumors.
Materials and methods
Single-cell cloning
CDb c e l l sg r o w ni nD u l b e c c o ’s modified Eagle’sm e d -
ium/Ham’s F-12 nutrient mixture containing 2% adult
bovine serum albumin, 5 ng/ml epidermal growth factor,
5 μg/ml insulin and 100 U/ml penicillin/streptomycin
were trypsinized, and a single-cell suspension at 1 mil-
lion cells/ml was prepared. The process for mammary
cell staining using Hoechst 33342 dye (B2261, St. Louis,
MO, USA) has been publishedp r e v i o u s l y[ 1 4 ] .T h e
Hoechst dye was excited at 350 nm and was fluores-
cence measured at two wavelength emissions of 450/20
band pass filter (Hoechst blue) and 675 EFLP optical fil-
ter (Hoechst red). Analysis and sorting were performed
on a triple laser MoFlo (Cytomation, Fort Collins, CO,
USA). After analysis, single cells from each side popula-
tion (SP) and non-side population (NSP) region were
sorted into individual wells of 96-well plates. For the
biclones, one cell from the SP region and one cell from
the NSP region were sorted into the same well.
Fat pad transplantation and pituitary isografts
Mammary epithelial clearance, transplantation proce-
dures and pituitary isograft procedures have been
described previously [15,16]. These procedures were
approved by the Institutional Review Board at Baylor
College of Medicine, Houston, TX, USA. One hundred
thousand cells from each clone were injected into the
cleared fat pads of syngeneic (BALB/c) female mice.
Eight weeks after cell transplantation fat pads were
excised and prepared for the various staining procedures
described in this section.
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of mammary outgrowths
Whole-mount staining
Mammary glands were removed and fixed in 10% for-
malin for 24 hours. Fixative was removed, and tissue
was placed in acetone for two incubations of 24 hours
each. Glands were pretreated for 1 hour each in 100%
and 95% alcohol, followed by staining overnight in
hematoxylin. The next morning glands were immersed
in running tap water for 1 hour, followed by dehydra-
tion in graded alcohol for 1 hour each at 70%, 95% and
100% (three times), as well as in xylene (three times).
The tissues were kept in methylsalicylate for long-term
storage. For X-gal staining, glands were fixed in 4% par-
aformaldehyde, followed by three washes using a buffer
containing 0.2% NP-40, 0.01% NaDOC and 2 mM
MgCl2 in 1× phosphate-buffered saline (PBS) and incu-
bated overnight at 37°C in X-gal solution containing 1
mg/ml X-gal. Tissues were then dehydrated as described
above, embedded in paraffin and sectioned.
Hematoxylin and eosin staining
Excised mammary outgrowths were fixed in 4% parafor-
maldehyde and then embedded in paraffin according to
established protocols. Slides containing 5-μms e c t i o n s
were deparaffinized in xylene (8400 laboratory grade,
Anapath brand; StatLab, Lewisville, TX, USA) and
hydrated through graded ethanol series (100%, 95%, 80%
and 70%), followed by hematoxylin staining (s212A Har-
ris hematoxylin with glacial acetic acid; Poly Scientific
(Bayshore, NY, USA) for 30 seconds and destaining in
acid ethanol (1 ml of concentrated HCl + 400 ml of
70% ethanol), followed by eosin staining (176 Eosin
Phloxine stain; Poly Scientific) for 45 seconds and dehy-
dration in graded ethanol (95% and 100%) and xylene
three times for 15 minutes each, followed by placement
of a coverslip onto the slide by using xylene-based Per-
mount (SP15-100 histological mounting medium, Fisher
Scientific, Pittsburgh, PA, USA).
Immunofluorescence and antibodies
IF was performed following tissue deparaffinization by
clearance in xylene and hydration through a graded
ethanol series as described above. Microwave antigen
retrieval (20 minutes) in 10 mM sodium citrate was per-
formed for all the antibodies used for IF. A 5% solution
of bovine serum albumin (BSA) in PBS + 0.5% Tween
20 was used as blocking buffer. For staining of cells
g r o w ni nt w od i m e n s i o n s( 2 D ) ,c e l l sw e r eg r o w no n
coverslip slides and fixed in 2% paraformaldehyde for 15
minutes at room temperature without antigen retrieval.
Sections were incubated with the following primary anti-
bodies overnight at 4°C: ERa rabbit polyclonal antibody
(SC-542, MC-20; Santa Cruz Biotechnology, Santa Cruz,
CA, USA), smooth muscle actin (SMA) antibody (A14,
A2547; Sigma, St. Louis, MO, USA), cytokeratin 5 (CK5)
rabbit polyclonal antibody (PRB-160P; Covance, Rich-
mond, CA, USA), CK6 rabbit polyclonal antibody (PRB-
169P; Covance), CK8 rat monoclonal antibody
(TROMA-1; Developmental Studies Hybridoma Bank,
University of Iowa, Iowa City, IA, USA), Na
+,K
+,2 C l
-
type I cotransporter (NKCC1) rabbit polyclonal antibody
(gift of Jim Turner, National Institutes of Health,
Bethesda, MD, USA) and p63 mouse monoclonal anti-
body (MS-1081-P, Thermo Fisher Scientific, Fermont,
CA, USA). Nuclei were counterstained with 4’,6-diami-
dino-2-phenylindole (Dapi) (Vector Laboratories, Burlin-
game, CA, USA) and TO-PRO-3 iodide (T3605,
Invitrogen, Carlsbad, CA, USA). Secondary antibodies
used were anti-rabbit Alexa Fluor 563 antibody, anti-
mouse Alexa Fluor 594 antib o d ya n da n t i - r a tA l e x a
Fluor 488 antibody (Invitrogen, Carlsbad, CA, USA). All
primary antibodies were used at a 1:200 concentration,
and secondary antibodies were used at a 1:500 concen-
tration. Confocal microscopy was performed using a
laser-scanning confocal microscope (model 510; Carl
Zeiss MicroImaging, Inc., Thornwood, NY, USA). The
acquisition software used was LSM Image Browser (Carl
Zeiss MicroImaging, Inc.). Phase-contrast images were
captured using an invertedm i c r o s c o p e( C K 4 0 - S L P ;
Olympus, Southend-on-Sea, Essex SS2 5QH, UK). The
acquisition software used was PhotoShop version 5.0
(Adobe, San Jose, CA, USA).
FACS and reagents
Primary antibodies used were anti-mouse CD29 fluores-
cein isothiocyanate (FITC)-conjugated antibody (102206;
Biolegend, San Diego, CA, USA), anti-mouse CD24 R-
phycoerythrin (PE)-conjugated antibody (553262; BD
Biosciences, San Diego, CA, USA), anti-mouse CD24
FITC-conjugated (553261; BD Biosciences), anti-mouse
CD49f FITC-conjugated antibody (557510; BD Bios-
ciences), biotin-conjugated hamster anti-mouse CD61
antibody (553345; BD Biosciences), anti-stem cell anti-
gen 1 (Sca-1)-PE antibody (553336; BD Biosciences) and
anti-mouse prominin 1 antibody (AC133, 12-1331;
eBioscience (San Diego, CA, USA). Biotin-conjugated
CD61 was labeled using streptavidin-APC (554067; BD
Biosciences). Isotype control staining was performed
using PE-conjugated anti-rat immunoglobulin G2a
(IgG2a) antibody (558067; BD Biosciences) and FITC-
conjugated mouse anti-rat IgG1 antibody (553892; BD
Biosciences). JSE3, 33A10, 50B8 and 44G3 antibodies
were supernatants used at 1:1 concentration for 45 min-
utes at room temperature. All other antibody cells were
stained at a final concentration of 1:200 for 30 minutes
on ice, followed by washes in Hanks’ balanced salt solu-
tion (Invitrogen, Carlsbad, CA, USA) containing 2% fetal
bovine serum. FACS analysis and data acquisition were
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FACSDiva-based software (BD Biosciences).
Intracellular staining and FACS analysis
Cells were harvested by trypsinization with 0.05% tryp-
sin-ethylenediaminetetraacetic acid (Invitrogen). Cells
were fixed for 15 minutes with Click-iT fixative (Invitro-
gen), permeabilized for 30 minutes with saponin-based
permeabilization buffer (Invitrogen) and stained with
primary CK5 antibody (1:50, PRB-160P; Covance) or
with the rabbit IgG immunoglobulin isotype control
antibody (BD Biosciences). Subsequently, samples were
counterstained with Alexa Fluor 488-conjugated goat
anti-rabbit secondary antibody (1:100; Invitrogen) and
resuspended in 300 μl of 1% BSA-PBS prior to analysis
with the LSR II flow cytometer. Data analysis was per-
formed using FlowJo software (Tree Star, Inc., Ashland,
OR, USA).
RNA isolation and quantitative real-time polymerase
chain reaction
Total RNA was isolated and reverse-transcribed (100 ng)
using the TaqMan Gene Expression Cells-to-CT Kit
(Ambion, Austin, TX, USA) following the manufac-
turer’s instructions. The mRNA transcript levels of the
housekeeping gene 18S and the target gene Elf5 were
evaluated using commercially available TaqMan primers
and probes (Hs03928990_g1, 18S; Mm00468732_m1
Elf5 (Applied Biosystems, Carlsbad, CA, USA)). The
resulting cDNA was diluted 1:15 and subjected to quan-
titative real-time polymerase chain reaction (qRT-PCR)
analysis in a 20-μl final reaction volume. Each sample
was run in triplicate for both the target and the normal-
i z e r ,a n dt h ea v e r a g ec y c l et h r e s h o l d( Ct)w a su s e di n
subsequent calculations. Each sample was also run as a
minus reverse transcriptase control to confirm lack of
DNA contamination. Gene expression was detected
using the ABI 7900 fast real-time PCR system (Applied
Biosystems). The 2-ΔΔ
Ct method was used to calculate
relative fold change values between samples, with one
control sample set to 1 and all other samples compared
to it.
Results
Single-cell cloning of CDb cells identified multipotent and
committed progenitors
To assess the stem progenitor cell potential of the SP
cells compared to the NSP cells, CDb cells were stained
using Hoechst dye 33342, followed by FACS analysis
and sorting of each population. Cells that effluxed the
dye appeared on the left side of a FACS analysis panel
and were referred to as SP cells. Cells that retained the
dye appeared on the right side and were referred to as
non-NSP cells. Procedures for isolation of SP and NSP
mammary cells have been described in detail previously
[14,17]. Five thousand sorted cells from each region
were transplanted into cleared fat pads of syngeneic
female mice and evaluated for outgrowth potential 6
weeks following transplantation. The results showed
that there was no difference in the outgrowth potential
of SP vs. NSP cells derived from the CDb parental cells
(Additional file 1). The outgrowth potential (take rate)
was calculated by dividing the number of fat pads con-
taining positive mammary outgrowths by the total num-
ber of fat pads transplanted. Because there was no
difference in repopulation ability between the SP and
NSP cells, single cells were sorted from each region,
expanded in vitro and transplanted to assess their out-
growth potential. In addition, biclones were made by
adding one SP cell to one NSP cell, expanded in vitro
and transplanted. One hundred thousand cells from 15
selected groups were transplanted into cleared fat pads
of syngeneic female mice to evaluate their outgrowth
potential. Eight weeks following transplantation fat pads
were excised and examined for the presence of mam-
mary outgrowths by whole-mount staining. If transplan-
tation of cells gave rise to distinguishable ductal and/or
alveolar structures, the groups were stated to possess
outgrowth potential. However, if the groups did not
show any in vivo growth or showed growth consisting of
no discernible mammary structures, they were referred
to as nonprogenitor populations, indicated by the “No
outgrowth” designation in Table 1, column 3. Groups 1
to 6 were designated as biclones, since they were derived
from two cells, one each from the SP and NSP regions.
We sorted and combined two cells to examine whether
the presence of both cell types (SP and NSP) was
required to generate an outgrowth. However, as seen in
Table 1, outgrowths were generated from clones that
arose from single SP or NSP cells. Clones 7 to 10 were
derived from single cells sorted from the SP region, and
clones 11 to 15 were derived from single cells sorted
from the NSP region (Table 1). All 15 groups were eval-
uated by transplantation to assess their outgrowth
potential. The biclones were not evaluated beyond out-
growth potential. Seven of the 15 groups gave rise to
mammary outgrowth (Table 1). The percentage of fat
pads filled and the fraction of positive outgrowths are
indicated. Three of five NSP-derived clones had out-
growth potential compared to one of the four SP-
derived clones. Transplantation of clone 9 generated
only alveolar structures in vivo and is referred to herein
as an alveolar progenitor. Transplantation of clone 12
generated only ductal structures and is referred to
herein as a ductal progenitor. Transplantation of clones
11 and 15 generated ducts and alveolar structures and
are referred to herein as multipotent progenitor popula-
tions. Clone 13 incorporated into the mammary lumen
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prior to transplantation and is referred to herein as a
luminal restricted progenitor. The outgrowth take rate
for the parental CDb cells injected at 100,000 cells/fat
pad is 100% (six of six; data not shown).
Figure 1 shows whole mounts (Figures 1A to 1D) and
hematoxylin and eosin staining (Figures 1E to 1H) of
outgrowths generated by the selected clones. As shown,
outgrowths generated from the parental CDb cells con-
sisted of ductal and alveolar structures (Figures 1A and
1E). In contrast, one of the clones referred to as a ductal
progenitor generated only ducts (Figures 1B and 1F),
while another clone referred to as an alveolar progenitor
generated alveoli with a very limited number of small
ducts (Figures 1C and 1G). Two of the clones generated
outgrowths consisting of ducts and alveoli and were
referred to as multipotent. Figures 1D and 1H are an
outgrowth generated from one of the multipotent pro-
genitor clones. Mice transplanted with cells from the
alveolar progenitor (Figure 2A) and the ductal progeni-
tor (Figure 2B) clones were exposed to prolactin, estro-
gen and progesterone using pituitary isografts. Despite
hormonal stimulation and subsequent retransplantation,
no alveolar differentiation was evident in any of the duc-
tal progenitor-derived outgrowths. These data demon-
strate that the ductal progenitor clone is devoid of
alveolar differentiation potential. In contrast, the alveolar
progenitor-derived outgrowths consisted of alveoli and a
limited number of small ducts. As shown in Figure 2A,
alveolar progenitor-derived outgrowths, with hormonal
stimulation, are capable of producing large lipid dro-
plets, a marker of alveolar differentiation. Cells from the
alveolar progenitor clone grown on Matrigel™ basement
membrane matrix (BD Biosciences, San Diego, CA,
USA) were also capable of expressing b-casein (data not
shown). Interestingly, as shown in Figures 2C to 2E, the
ducts generated from the ductal progenitor clone
showed loss of normal directional cues and formed
intraductal papillary hyperplasia (IDH). About 10% to
50% of the ducts showed this IDH phenotype. The
appearance of IDH lesions was independent of hormo-
nal stimulation and was seen in both virgin and hor-
monally stimulated transplants. The reason for this
abnormal growth pattern is not known and may be
related to a deficiency in guidance cues imposed by
other missing cell types or by genetic mutations.
Table 1 Transplantation results of the CDb-derived clones
a
Clone Source Progenitor potential Outgrowth rate Number of fat pads filled, n (%)
1 Bi - 6/12 6 (50%)
2 Bi - 0/12 No outgrowth
3 Bi - 6/8 4 (25%)
2 (75%)
4 Bi - 7/7
5 Bi - 0/9 No outgrowth
6 Bi - 0/11 No outgrowth
7 SP-1 - 0/12 No outgrowth
8 SP-2 - 0/12 No outgrowth
9 SP-3 Alveolar 12/12 6 (50%)
6 (25%)
10 SP-4 - 0/10 No outgrowth
11 NSP-1 Multipotent 12/12 6 (75%)
6 (50%)
12 NSP-2 Ductal 7/10 6 (75%)
1 (25%)
13 NSP-3 Luminal 0/6 No outgrowth
14 NSP-4 - 0/3 No outgrowth
15 NSP-5 Multipotent 5/8 2 (75%)
3 (25%)
aCDb = COMMA-D cell line engineered to express b-galactosidase; No outgrowth = no discernible mammary structures; SP = side population; NSP = non-side
population; Bi = biclonal, referring to the groups derived from a single SP cell and a single NSP cell. The groups were either derived from a single SP cello ra
single NSP cell (clones 7 to 15) or were biclonal and derived from one SP mixed with one NSP (clones 1 to 6). Transplantation of clone 9 or SP-3 generated
alveolar-only structures in vivo and was referred to as the alveolar progenitor clone. Transplantation of clone 12 or NSP-2 generated ductal-only structures and
was referred to as the ductal progenitor clone. Clones 11 (NSP-2) and 15 (NSP-5) generated ducts and alveolar structures and were referred to as multipotent.
Clone 13 or NSP-3 incorporated into the lumen when mixed with total mammary epithelial cells prior to transplantation and was referred to as luminal.
Outgrowth take rate was calculated by dividing the number of positive fat pads containing any mammary outgrowths divided by the total number of fat pads
transplanted. The number of fat pads filled refers to the percentage of fat pads containing mammary outgrowths. The numbers outside the parentheses refer to
the number of fat pads containing a mammary outgrowth. The percentages inside the parentheses refer to the percentage of fat pads containing a mammary
outgrowth.
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clones. (A and E) Transplantation of COMMA-D cell line engineered to express b-galactosidase (CDb) parental cell line generates outgrowths
containing ductal and alveolar structures. (B and F) Ductal progenitor cells give rise to outgrowths containing ducts only. (C and G) Alveolar
progenitor clone generates mainly alveoli and a limited number of small ducts. (D and H) Multipotent progenitor clone generates outgrowths
containing ductal and alveolar structures. Figures 1A to 1D are whole-mount-stained images taken at ×3.2 original magnification. Figures 1E to
1H are hematoxylin and eosin-stained images taken at ×10 original magnification.
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appropriate luminal or basal orientation
The expression of mammary-specific basal markers p63,
CK5 and SMA, as well as luminal markers CK8, NKCC1
and ER, was examined using IF in outgrowths generated
from the distinct progenitor clones. These studies
showed that the majority of outgrowths contained all
the mammary cell types in the correct luminal or basal
orientation (Figures 3A to 3L). In most of the out-
growths, there was appropriate basal expression of
S M A ,C K 5a n dp 6 3( F i g u r e s3 At o3 L )a n dl u m i n a l
expression of CK8 and NKCC1 (Figures 3A to 3K). As
described earlier regarding Figure 2, the outgrowths
generated by transplantation of the ductal progenitor
clone showed a normal ductal phenotype as well as an
IDH phenotype. The latter phenotype resulted in the
expression of CK5, the basal marker, inside some of the
disorganized ducts (data not shown). These results
demonstrate a model of mammary development where
ductal and alveolar progenitors are independently cap-
able of generating luminal as well as basal cell types.
As shown in Figures 3C, F, I and 3L, nuclear ER
expression was undetectable in the CDb-derived
outgrowths, although it was readily detectable in the
normal BALB/c mammary glands (Figure 3L). This was
surprising, since many studies have reported the impor-
tance of ER expression for normal mammary develop-
ment [18,19]. However, studies using mouse models
with complete germline deletion of ER (ER
-/
-)h a v e
shown that ER was not required for prepubertal mam-
mary development, since at 3 weeks of age there was no
difference between the mutant and wild-type littermates
in the formation of a rudimentary mammary ductal tree
[19]. Nevertheless, there was a significant difference in
ductal elongation postpuberty in female mice lacking ER
[19]. Furthermore, Medina and colleagues [20] charac-
terized p53-null preneoplastic mammary outgrowth
lines which lacked ER expression but retained normal
ductal alveolar outgrowth potential. The outgrowths
were immortal and progressed through IDH and carci-
noma over time. Therefore, ER may not be required for
mammary development in the CDb-derived outgrowths,
since they also lack wild-type p53 gene expression. The
outgrowths were also examined for the expression of
progesterone receptor (PR). PR expression was solely
extranuclear in the outgrowths generated from all
Figure 2 Hematoxylin and eosin (H&E) staining of alveolar progenitor clone makes lipid droplets indicative of alveolar differentiation.
(A) Alveolar progenitor-derived outgrowths following hormonal stimulation using pituitary isografts show the formation of lipid droplets inside
the lumen. (B) Ductal progenitor outgrowths, shown for comparison, are incapable of alveolar differentiation, and the ducts lack the ability to
form lipid droplets. (C to E) Intraductal papillary hyperplasia (IDH) generated by the ductal progenitors. Arrows indicate IDH lesions. H&E images
taken at ×20 original magnification.
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not shown). Interestingly, extranuclear PR expression
has been implicated in the activation of Src and mito-
gen-activated protein kinase (MAPK) that lead to cancer
cell proliferation [21]. These interactions may also med-
iate hyperplastic growth of CDb-derived outgrowths and
their progression to tumorigenesis.
High CK5 expression correlates with outgrowth potential
CDb progenitor clones were examined for the expres-
sion of specific CKs and surface markers known to be
expressed by mammary stem, progenitor and differen-
tiated cells grown in 2D. These included markers of
mouse mammary repopulating cells (CD24
+/CD29
high
and CD24
+/CD49f
high), luminal ER-positive (CD24
+/AC133
+), Sca-1 (hematopoietic stem progenitor cell
marker) and luminal progenitors (CD29
low/CD24
+CD61
+) [3-6,22]. Other surface markers analyzed included
JSE3, 33A10, 50B8 and 44G3 (monoclonal antibodies
developed in the laboratory of Dr Around Sonnenberg
[23]) and aldehyde dehydrogenase (Aldefluor Kit, Stem
Cell Technologies, Vancouver, BC, Canada). Addition-
ally, the expression of CK5, CK8, CK6, SMA, NKCC1,
total p63, TA p63 and ΔN p63 were examined by IF
staining on cells grown in 2D culture, and additional
staining was performed to analyze P63, TA p63, ΔN p63
and CK5 expression by FACS. P63 is a member of the
p53 family. It is critical in the development of stratified
epithelial tissues such as epidermis, breast and prostate.
P63 is expressed in at least six isoforms that can be clas-
sified into two groups: those with a transactivating
domain (TAp63) and those that lack this domain
(ΔNp63) [24].
IF studies for intracellular markers were done by
counting an average of about 500 cells/marker. These
studies showed that among the markers tested, only
high expression of CK5 correlated with a clone’so u t -
growth potential (Figure 4). As shown, the three pro-
genitor clone types, multipotent, ductal and alveolar,
expressed CK5 with a mean fluorescence intensity (MFI)
of 1 × 10
4.5 (pink histograms). The clones that showed
no in vivo outgrowth potential showed low-intensity
expression of CK5 with a MFI of 1 × 10
3.7 (blue histo-
grams). Interestingly, the alveolar progenitor and ductal
progenitor clones showed two peaks: a low-intensity
peak (blue histogram) and a high-intensity peak (pink
Figure 3 Immunofluorescence (IF) staining of CDb-derived progenitor clones showing appropriate basal or luminal orientation. (A to
C) CDb multipotent outgrowths. (D to F) Ductal-limited outgrowths. (G to I) Alveolar-limited outgrowths. (J to L) Adult primary mammary
outgrowths (primary BALB/C). (A, D, G and J) Na
+,K
+, 2Cl
- type I cotransporter (NKCC1) (red) and mouse smooth muscle actin (SMA) (green). (B,
E, H and K) Cytokeratin 5 (CK5) (red) and CK8 (green). (C, F, I and L) p63 (green) and nuclear estrogen receptor (ER) (red). The nuclei were
counterstained with 4’, 6-diamidino-2-phenylindole and TO-PRO-3 iodide.
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intensity peak expression of CK5 may be related to the
existence of a heterogeneous population of luminal and
basal cells. The expression of CK5 by the subpopulation
of cells representing mammary repopulating activity
(Lin
-CD24
+CD29
high) has been proposed [25-27].
Furthermore, Deugnier and colleagues [28] showed that
Sca-1
high cells in the CDb cell line possessed signifi-
cantly higher morphogenic potential and contained a
significantly higher percentage of cells expressing the
basal markers CK5 and p63 compared to Sca-1
-/low cells
(about 95% vs. 5%). The molecular mechanism underly-
ing CK5 expression in stem and progenitor cells is not
clear at this point and requires further investigation.
No correlation could be found between the expression
of CK8, NKCC1, CK6, SMA, total and isoform-specific
(TA and ΔN) p63 and Aldefluor and progenitor activity
(data not shown). Our data show that Sca-1 and p63
expression levels change in vitro in cells grown in 2D,
and therefore their expression could not be correlated
with the clones’ outgrowth potential (data not shown).
Therefore, on the basis of our data, Sca-1 expression
may not be correlated with mammary progenitor poten-
tial. The expression of individual p63 isoforms, TA and
ΔN, by IF and FACS (ΔN and TA), also was not asso-
ciated with in vivo progenitor potential (data not
shown).
Restricted mammary luminal progenitor cells may exist in
the mouse mammary gland
Clone 13, referred to as the luminal-restricted progeni-
tor, did not show any in vivo outgrowth potential, but
incorporated into the ductal lumen when coinjected
with normal mammary epithelial cells (Figure 5A). The
mixing experiment was done because the luminal pro-
genitor clone was derived from b-gal-expressing CDb
cells and would be distinguished from the normal mam-
mary epithelial cells by X-gal staining. As expected, the
luminal progenitor clone expressed significantly higher
CK8 (a mammary luminal marker) by IF and Elf5 (a
luminal progenitor marker) by qRT-PCR (Figures 5B
and 5C). On the basis of these results, we propose that
this clone represents a luminal-restricted progenitor
clone.
Discussion
A role for stem cells or distinct progenitor cells as the
cells of origin in many types of cancer has been pro-
posed [29-32]. These studies have led to the hypothesis
that in many types of cancers, including breast cancer,
distinct progenitors and their abrogated self-renewal
pathways may ultimately underlie the mechanisms of
heterogeneity observed among subtypes of human breast
cancer [33]. The identification and further characteriza-
tion of distinct mammary progenitors are necessary pre-
requisites for testing this hypothesis. Single-cell cloning
of an immortalized mammary cell line, CDb,w a su t i -
lized to isolate mammary-specific multipotent, ductal
and alveolar progenitor clones. Molecular phenotyping
showed that mammary progenitors express significantly
higher levels of CK5.
Sca-1 expression was not associated with outgrowth
potential of the clones. The unique expression of Sca-1
in stem and progenitor subpopulations has been
Figure 4 CK5 is uniquely expressed by the clones that possess outgrowth potential. The intensity of CK5 expression was assessed by FACS
using a CK5-specific antibody conjugated to Alexa Fluor 488. The histogram shows the intensity of CK5 expression in clones devoid of
outgrowth (red) (clones 1, 8, 10, 13 and 14) compared to the clones that formed outgrowths in vivo (blue) (alveolar, ductal and multipotent
progenitors). The isotype control is shown in black.
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of Ly6 gene family, is a glycosylphosphatidylinositol-
anchored cell surface protein. Sca-1, when combined
with other markers, c-kit and the hematopoietic lineage,
identifies hematopoietic stem cells in the bone marrow
[34]. However, its role as a stem or progenitor cell mar-
ker in the mammary gland has been controversial [35].
CDb clones that possess outgrowth potential contain
significantly higher levels of CK5 expression. The
expression of CK5 in mammary stem cells has been pro-
posed previously [25-27]. In human breast tissue, there
is a small population of CK5-expressing cells (5%) that
lack the expression of other markers of glandular, CK8,
CK18, CK19 or myoepithelial cells (SMA) [25]. Addi-
tionally, the stem cell subpopulation in normal mouse
mammary gland (Lin
-CD24
+CD29
+) is enriched in the
expression of CK5 and displays a basal phenotype
[27,36]. Dontu and colleagues [26] showed that mam-
mospheres were enriched in undifferentiated cells and
expressed the basal markers CK5 and CK14. These data
demonstrate that high-level CK5-expressing cells may
represent an enriched population of stem and progeni-
tor cells. It will be interesting to explore whether CK5
serves only as a stem cell marker or perhaps is coregu-
lated with a critical stem cell gene.
In light of the important role of estrogen signaling
during normal mammary development, it was surprising
that the CDb-derived outgrowths lacked ER expression.
T h i sm a yb eb e c a u s et h eC D b-derived outgrowths
express mutated p53. It has been demonstrated that
some of the p53-null preneoplastic mammary out-
growths lack ER expression, although they do develop
normally [37]. Therefore, the requirement for ER
expression may apply only to wild-type p53-expressing
mammary glands. Furthermore, ER
-/
- mammary glands
develop normally until puberty. However, there is
stunted ductal outgrowth after puberty. Therefore, the
outgrowths generated by the CDb-derived clones may
develop without the expression of ER because the CDb
cells lack a functional p53 gene and/or the outgrowths
grow in response to prepubertal growth hormones such
as the parathyroid hormone signaling pathway [18]. The
Figure 5 Luminal-restricted clone incorporates into the ductal lumen in vivo and expresses significantly higher luminal-specific
markers CK8 and Elf5. (A) The luminal-restricted clone incorporated into the ductal lumen when mixed with primary mammary epithelial cells
prior to transplantation. The luminal-restricted cells stained blue upon X-gal staining, since they were derived from CD cells previously
engineered to express b-gal. (B) Expression of Elf5 by quantitative real-time polymerase chain reaction is significantly higher in the luminal-
restricted clone compared to the remaining progenitor clones. GAPDH, glyceraldehyde 3-phosphate dehydrogenase. (C) Higher percentage of
cells in the luminal-restricted clone expressed CK8 compared to the other progenitor clones and nonprogenitor clones 7, 8, 10, and 14. CK8
expression was measured by IF using specific antibody. An average of 500 cells were counted in each group. The x-axis represents the
percentage of CK8-positive cells divided by the total number of cells counted. On the y-axis, MP/clone 11 refers to multipotent clone 11 and
MP/clone 15 refers to multipotent clone 15.
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play an important role in mammary ductal branching
morphogenesis and alveolar development, as well as in
mammary tumorigenesis [18,21]. Interestingly, the
expression of PR was extranuclear in the outgrowths
derived from the progenitor clones. It has been demon-
strated that PR may bind and activate Src-1 and MAPK
signaling pathway and thus promote the proliferation of
breast cancer cells. These extranuclear effects of PR may
mediate mammary hyperplasia and tumor progression
in the outgrowths derived from the CDb cells.
The CDb cell line is unique in that transplantation of
cells into the epithelium-free fat pads of syngeneic
female mice generates mammary outgrowths that even-
tually progress to tumors over time in vivo.M a m m a r y
tumors eventually form because the CDb cell line har-
bors two distinct p53 mutations. Thus, the model pro-
vides a unique opportunity to study the cellular and
molecular mechanisms underlying mammary tumor pro-
gression beginning at the normal stages.
Figure 6 shows a hypothetical model of mammary
development based on the findings in this study. As illu-
strated, mammary development begins by asymmetric
self-renewal in a stem cell, which generates multipotent
and bipotent ductal and alveolar progenitor cells. Each
ductal and alveolar progenitor cell is bipotent, expresses
high CK5 levels and may give rise to luminal- and
myoepithelial-restricted progenitors. The luminal and
myoepithelial progenitors give rise to the ductal and
alveolar structures. Upon commitment to transient
amplification and differentiation, restricted progenitor
cells may downregulate CK5 expression.
Conclusions
The utilization of clones with distinct multipotent, duc-
tal, alveolar and restricted luminal progenitor activity
will provide valuable tools for studying the unique biol-
ogy of these progenitor populations. The identification
and molecular characterization of self-renewal pathways
in stem and distinct progenitor cell subpopulations will
not only reveal normal mechanisms for development
but also help to elucidate the molecular pathways that
are misregulated during tumorigenesis, ultimately lead-
ing to tumor heterogeneity.
Additional material
Additional file 1: Transplantation results comparing SP, NSP and
mixed (SP and NSP) cells sorted from CDb cells.C D b cells sorted
from each region representing SP, NSP, sorted and mixed SP and NSP
showed similar outgrowth efficiency following in vivo fat pad
transplantation of 5,000 cells. The x-axis of the bar graph refers to the
fraction of fat pads containing positive outgrowths over the total
number of fat pads transplanted in each sorted SP, NSP and mixed
group. SP, side population; NSP, non-side population; CDb, COMMA-D
cell line engineered to express b-galactosidase.
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